Advisory Team

The Advisory Team at Enterin leverages its extensive scientific and regulatory expertise to guide the development and implementation of novel drug therapies that repair the dysfunctional gut-brain axis in patients with neurodegenerative diseases. With a diverse group of scientific advisors, board members, and regulatory strategists, the team ensures that Enterin's groundbreaking treatments meet rigorous scientific and regulatory standards while advancing innovative research and clinical strategies.